
|Videos|April 26, 2016
Tanios Bekaii-Saab, MD: Strategies to Increase RAS Testing
Advertisement
What strategies can be used to increase the percentage of patients who receive recommended RAS testing?
There are a number of ways to do this. One is to increase the level of education for pathologists for pathologists, as well as gastroenterologists and surgeons. So the folks who see the patients first before they send them to an oncologist, they need to know about the importance of this test. It should be more automatically thought of than it is today.
Unresectable Colon Cancer: Case 2
52-year-old woman newly diagnosed with metastatic CRC and is genotyped as part of her initial work up.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5








































